Osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinical diagnosis of joint pain due to inflammation in the intra and / or peri-articular structures by a doctor and presence of pain caused by the disease mentioned during the initial evaluation, of both sexes and any ethnic group will be included in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria are: pregnant patients with a history of bee sting allergy and other therapies; hx of gastrointestinal bleeding, gastric perforation; kidney disease, liver disease; current history of alcoholism; use of anticoagulants; prosthetic implants or pacemaker; serious uncontrolled chronic diseases (high blood pressure, diabetes mellitus, heart disease and other diseases that, by their nature or by the proposed treatment, may interfere with the proposed assessment). Individuals who make use of various pharmacological therapies will be evaluated professional pharmaceutical pain able to understand possible pharmacological interactions, deciding for the insertion or exclusion of this individual in the current research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of pain intensity related to underlying pathology according to the visual pain scale, with an expected reduction of 2 points in the intensity of the scale used. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of joint function, verified by measuring the range of motion and muscle strength, with an increase of at least 10º in the range of articular movement verified by goniometry.;Improved functionality with reduced indexes in the Lequesne functional questionnaire, reducing the degree of functional impairment by one level.;Maintenance of biochemical parameters, without changes in blood count, renal and hepatic profile, analyzed using biochemical analysis devices. | — |
Countries
Brazil
Contacts
Pós Graduação em Ciências da Saúde